Keurig Dr Pepper officer plans 24K-share sale

An officer of Keurig Dr Pepper has filed a Rule 144 notice to sell 24,000 KDP common shares through a broker.

Rhea-AI Filing Summary

Keurig Dr Pepper Inc. (KDP) received a notice that officer Mary Beth DeNooyer intends to sell shares of the company’s common stock under Rule 144. The planned sale covers 24,000 shares of common stock through J.P. Morgan Securities LLC on or after September 8, 2026, on NASDAQ.

The filing lists how these shares were acquired, including an open-market purchase on November 5, 2019, and multiple executive compensation grants between March 2, 2025, and March 3, 2026.

Key Figures

Shares proposed for sale: 24,000 shares Aggregate market value: $782,160 Intended sale date: September 8, 2026 +3 more

6 metrics

Shares proposed for sale 24,000 shares Common stock to be sold under Rule 144 through J.P. Morgan Securities LLC

Aggregate market value $782,160 Value of 24,000 shares of common stock covered by the notice

Intended sale date September 8, 2026 Date from which sales under this Form 144 may begin

Open-market purchase 2,878 shares Common stock purchased on November 5, 2019

Executive compensation grant 5,521 shares Common stock received as compensation on March 2, 2025

Executive compensation grant 6,234 shares Common stock received as compensation on March 1, 2026

Key Terms

Rule 144, Open Market, Executive Compensation, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Open Market financial

"Common Stock | 11/05/2019 | Purchase | Open Market |"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

Executive Compensation financial

"Common Stock | 03/02/2025 | Executive Compensation | Issuer |"

Payments and benefits given to a company's top leaders — including base salary, cash bonuses, stock awards, options and retirement or perquisites — designed to compensate and motivate them. Investors care because these packages affect a company’s costs, influence executives’ decisions and signal how well management’s interests line up with shareholders’; like a captain’s contract, the structure of pay can encourage safe navigation toward long-term gains or risky short-term moves that hurt returns.

attorney-in-fact regulatory

"as agent and attorney-in-fact for Mary Beth DeNooyer"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for KDP disclose?

It discloses that officer Mary Beth DeNooyer plans to sell 24,000 shares of Keurig Dr Pepper Inc. common stock under Rule 144, using J.P. Morgan Securities LLC as broker, with sales intended to begin on or after September 8, 2026 on NASDAQ.

How many Keurig Dr Pepper (KDP) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 24,000 shares of Keurig Dr Pepper Inc. common stock. The filing also reports an aggregate market value of $782,160 for these shares at the time of the notice.

Who is selling KDP shares and through which broker?

The planned sale is for the account of Mary Beth DeNooyer, an officer of Keurig Dr Pepper Inc. The broker designated to execute the transaction is J.P. Morgan Securities LLC, which signed the notice as agent and attorney-in-fact.

When did the seller acquire the KDP shares listed in the Form 144?

The filing lists acquisitions including an open-market purchase of 2,878 shares on November 5, 2019 and multiple executive compensation grants on March 2, 2025, March 3, 2025, March 12, 2025, March 1, 2026, March 2, 2026, and March 3, 2026.

How were the KDP shares being sold under this Form 144 originally obtained?

According to the notice, 2,878 shares were acquired via an open-market purchase on November 5, 2019, while additional blocks of 5,521, 2,320, 2,974, 6,234, 1,840, and 2,233 shares were received as executive compensation from the issuer between March 2025 and March 2026.

On which market are the KDP shares in this Form 144 expected to be sold?

The notice states that the 24,000 shares of Keurig Dr Pepper Inc. common stock covered by the Form 144 are expected to be sold on NASDAQ starting on or after September 8, 2026, subject to Rule 144 conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 07:05 PM EDT Accepted by SEC EDGAR 09/08/2026 - 07:05 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001587484
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Keurig Dr Pepper Inc.
SEC File Number	001-33829
Address of Issuer	6425 Hall of Fame Lane Frisco TEXAS 75034
Phone	800-527-7096
Name of Person for Whose Account the Securities are To Be Sold	Mary Beth DeNooyer
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue, 10th Floor New York NY 10017	24000	782160	1360826038	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/05/2019	Purchase	Open Market			2878	11/05/2019	Cash
Common Stock	03/02/2025	Executive Compensation	Issuer			5521	03/02/2025	Compensation
Common Stock	03/03/2025	Executive Compensation	Issuer			2320	03/03/2025	Compensation
Common Stock	03/12/2025	Executive Compensation	Issuer			2974	03/12/2025	Compensation
Common Stock	03/01/2026	Executive Compensation	Issuer			6234	03/01/2026	Compensation
Common Stock	03/02/2026	Executive Compensation	Issuer			1840	03/02/2026	Compensation
Common Stock	03/03/2026	Executive Compensation	Issuer			2233	03/03/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Mary Beth DeNooyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)